Dose-dependent targeted suppression of P-glycoprotein expression and function in Caco-2 cells

Area of Science:

• Pharmacology
• Molecular Biology
• Cell Biology

Background:

• P-glycoprotein (Pgp), encoded by ABCB1, reduces oral drug bioavailability.
• Current Caco-2 cell models use small molecule modulators, which can interact with other transporters.
• RNA interference offers a specific method to study gene function.

Purpose of the Study:

• To develop a novel in vitro model using siRNA for dose-dependent suppression of ABCB1 in Caco-2 cells.
• To assess the efficacy and duration of Pgp silencing using siRNA.
• To evaluate the utility of this model in drug permeability studies.

Main Methods:

• Caco-2 cells were transfected with chemically modified siRNA-lipid complexes.
• ABCB1 mRNA and Pgp protein levels were quantified using RT-qPCR and Western blot, respectively.
• Bidirectional transport studies with rhodamine 123 were performed to measure Pgp efflux.

Main Results:

• A single 4-hour transfection with ≥100 nM siRNA reduced ABCB1 mRNA by >85% at day five.
• Pgp protein levels were suppressed for up to 9 days post-transfection.
• Silencing Pgp significantly reduced rhodamine 123 efflux and intracellular accumulation.

Conclusions:

• siRNA-mediated, dose-dependent degradation of Pgp in Caco-2 cells provides a robust model for assessing drug efflux.
• This approach offers significant improvements over existing methods for ABCB1 suppression in Caco-2 models.
• This technique will be valuable for future drug permeability and bioavailability studies.